Systemic effect of catumaxomab in a patient with metastasized colorectal cancer: a case report.

BMC Cancer · 2013 · PMC3880167 · PMID 24380380

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

Although the study was not powered to detect a difference in overall survival, OS showed a positive trend for the catumaxomab group and was significantly prolonged in patients with gastric cancer patients compared to paracentesis alone (71 versus 44 days;p = 0.0313).

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.